These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6815841)

  • 1. Effect of delayed refrigeration on plasma factors in whole blood collected in CPDA-2.
    Sohmer PR; Bolin RB; Scott RL; Smith DJ
    Transfusion; 1982; 22(6):488-90. PubMed ID: 6815841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical effects of CPDA-2-drawn red blood cells of delayed refrigeration prior to component preparation.
    Moore GL; Ledford ME; Merydith A
    Transfusion; 1982; 22(6):485-7. PubMed ID: 7147327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo viability of red blood cells stored in CPDA-2.
    Sohmer PR; Moore GL; Beutler E; Peck CC
    Transfusion; 1982; 22(6):479-84. PubMed ID: 7147326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
    Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
    Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vivo comparison of CPD and CPDA-2 preserved platelet concentrates after an 8-hour preprocess hold of whole blood.
    Bolin RB; Cheney BA; Smith DJ; Gildengorin V; Shigekawa R
    Transfusion; 1982; 22(6):491-5. PubMed ID: 7147328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
    Kurup PA; Arun P; Gayathri NS; Dhanya CR; Indu AR
    Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold-stored leukoreduced CPDA-1 whole blood: in vitro quality and hemostatic properties.
    Sivertsen J; Braathen H; Lunde THF; Kristoffersen EK; Hervig T; Strandenes G; Apelseth TO
    Transfusion; 2020 May; 60(5):1042-1049. PubMed ID: 32187700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G; Dende D
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood services.
    McEvoy PM; Kahn RA; Miller WV
    Transfusion; 1982; 22(6):532-4. PubMed ID: 7147334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulation and function of human platelets isolated from units of CPDA-1, CPDA-2, and CPDA-3 anticoagulated blood and frozen with DMSO.
    Vecchione JJ; Melaragno AJ; Hollander A; Defina S; Emerson CP; Valeri CR
    Transfusion; 1982; 22(3):206-9. PubMed ID: 7090033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol.
    Antonelou MH; Kriebardis AG; Stamoulis KE; Economou-Petersen E; Margaritis LH; Papassideri IS
    Transfusion; 2010 Feb; 50(2):376-89. PubMed ID: 19874562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
    Wiltshire M; Cardigan R; Thomas S
    Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pre-storage whole-blood leukocyte reduction on cytokines/chemokines levels in autologous CPDA-1 whole blood.
    Nagura Y; Tsuno NH; Tanaka M; Matsuhashi M; Takahashi K
    Transfus Apher Sci; 2013 Oct; 49(2):223-30. PubMed ID: 23462351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequate survival of red cells from units "undercollected" in citrate-phosphate-dextrose-adenine-one.
    Davey RJ; Lenes BL; Casper AJ; Demets DL
    Transfusion; 1984; 24(4):319-22. PubMed ID: 6464155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation compared in stored whole blood with various nutrient-anticoagulant solutions.
    Knight JA; Searles DA; Blaylock RC
    Ann Clin Lab Sci; 1993; 23(3):178-83. PubMed ID: 8323251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
    Dawson RB; Fagan DS; Meyer DR
    Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.
    DePalma L; Criss VR; Luban NL
    Transfusion; 1993 Sep; 33(9):717-20. PubMed ID: 8212116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioequivalence of frozen plasma prepared from whole blood held overnight at room temperature compared to fresh-frozen plasma prepared within eight hours of collection.
    Dumont LJ; Cancelas JA; Maes LA; Rugg N; Whitley P; Herschel L; Siegel AH; Szczepiorkowski ZM; Hess JR; Zia M
    Transfusion; 2015 Mar; 55(3):476-84. PubMed ID: 25233805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 24-hour whole-blood storage on plasma clotting factors.
    O'Neill EM; Rowley J; Hansson-Wicher M; McCarter S; Ragno G; Valeri CR
    Transfusion; 1999 May; 39(5):488-91. PubMed ID: 10335998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.